Angemeldet als:
filler@godaddy.com
Angemeldet als:
filler@godaddy.com
January 17, 2023: Despite record-breaking corporate and investor attendance, the event stayed true to its roots of being welcoming, personal, and organized to ensure the highest quality of interaction. Many thanks to all participants for helping us to continue to make this event so special and, perhaps most importantly, fun.
We look forward to our next Octavian Seminar, which will take place from January 11 - 13, 2024, in Zurich and Flims. Please save the dates!
Truly Yours:
Team Octavian
November 4, 2022: Team Octavian would like to thank Swatch Group for hosting our institutional investor clients. The highlights of this reverse roadshow event included a visit at Longines in St-Imier and a Q&A session with management at Swatch Group's HQ's in Biel.
It's been a very special day! We at Team Octavian are grateful, honoured and literally over the moon!
May 18, 2022: SIG Group (SIX: SIGNN) successfully raised approximately EUR 204 million through the placement of 11 million new shares at a price of CHF 19.40 per share.
Octavian was acting as Selling Agent in the context of the capital increase.
Click here for further information on the SIG capital increase.
January 21, 2022: We like to thank all participants of The Octavian Seminar 2022.
This year saw our seminar return to its rightful format, a physical gathering of corporates and investors keen to share ideas and views, in the welcoming and friendly environment we have come to love. It was also our largest conference to date, with 22 scheduled presentations, 40 companies in attendance and over 250 one-on-one meetings. The collective joy of being able to meet face-to-face was palpable, with many veteran attendees saying it was our best seminar to date.
For those of you that could not make it this year, we really hope you will join us all next year, from January 12 - 14, 2023, in both Zurich and Flims. Please save the dates!
Truly Yours:
Team Octavian
February, 18, 2021: Team Octavian is pleased to announce that we have advised FERI Group on the acquisition of the Swiss asset manager Limmat Wealth Group. With the takeover, FERI is strengthening its Zurich location and continuing its previous growth course.
Click here for the press release of FERI
January, 15, 2021: Team Octavian is proud to inform that we successfully held on Thursday and Friday January 14 - 15, 2021 our 4th annual investor conference named "The Octavian Seminar". It was the 26th edition in the long tradition of the Flims Seminar, and the first fully virtual one.
With 40 Corporates from Switzerland and more than 150 institutional investors we hosted around 500 corporate access interactions. As always, the level of debate has been very high and professional. Interested parties can consult the agenda of the seminar here.
We thank all Corporates and Investors for their engaged discussions and look forward to our next year's seminar, which will take place on January 13 to 15, 2022; hopefully, once again in the more traditional physical setting. In the meantime, we wish all participants a successful 2021.
Truly Yours:
Team Octavian
October 20, 2020: Kuros Biosciences (SIX: KURN) announces the final number of Offered Shares and gross proceeds from its Rights and Share Offering.
Octavian was acting as Placement Agent in this transaction.
Click here for further information on the Kuros capital increase.
January 22, 2020: Another Flims Seminar is behind us; the third under Octavian and the 25th since inception by Bellevue. It was by far the largest (39 companies attending) and for the Octavian Team, one of the most rewarding Seminar. Click here for the Seminar Agenda 2020.
Subscribers can access the Seminar Summary and Review report on our Bloomberg homepage {RESP OCTV <GO>}
Preparations for the 2021 edition have already started; it will take place from January 14 - 17, 2021, in Zurich and Flims. Please save the dates!
December 3, 2019: Kuros Biosciences (SIX: KURN) announces the final number of Offered Shares and gross proceeds from its Rights Offering and Share Offering
Octavian was acting as Placement Agent for Kuros BioSciences in three consecutive follow-on offerings in 2017, 2018 and 2019 raising an aggregate CHF 45 million of gross proceeds.
Click here for further information on the Kuros capital increase inluding the prospectus.
Click here for our Octavian Capital Increase Case Study
For older Octavian news click here